Characterizing Immune Infiltration via Single-Sample Gene Set Enrichment Analysis

23 concepts24 papers1 proposal

In modern oncology and immunology, a central challenge is the "deconvolution" of heterogeneous tissues. When researchers sequence the RNA of a tumor or an inflamed tissue, they typically generate "bulk" data—a single average signal representing millions of different cells. To understand why a patient might resist therapy or succumb to disease, researchers must look past this average to see the specific composition of the immune microenvironment.

Single-sample Gene Set Enrichment Analysis (ssGSEA) has emerged as a primary computational tool for this task. By transforming bulk transcriptomic data into scores for specific cell types and biological pathways, it allows researchers to profile the immune landscape of individual samples without the need for expensive single-cell sequencing or physical cell isolation.

The Intuition: From Averages to Enrichment

Standard Gene Set Enrichment Analysis (GSEA) is designed to find differences between groups (e.g., healthy vs. diseased). In contrast, ssGSEA calculates an enrichment score for each individual sample.

As described by Yanfei Jia et al., the method works by comparing the gene expression profile of a single sample against validated "gene signatures"—lists of genes known to be uniquely expressed by specific cells, such as T-cells, macrophages, or neutrophils. If the genes in a "neutrophil signature" appear at the top of a sample's expression ranking, the ssGSEA algorithm assigns that sample a high enrichment score for neutrophils.

This approach effectively treats the transcriptome as a fingerprint. As Peng Liu et al. and the authors of Comprehensive analysis of anoikis-related gene signature in ulcerative colitis using machine learning algorithms note, this transforms raw gene counts into a functional map of immune infiltration and metabolic activity at the individual patient level.

Mapping the Immune Microenvironment

The primary power of ssGSEA lies in its ability to correlate specific molecular markers with the presence of immune cells. This helps researchers identify "hub genes" that might be driving immune evasion or chronic inflammation.

For example, Zhihong Ren et al. used ssGSEA in High expression of B4GALT1 is associated with poor prognosis in acute myeloid leukemia to show that the gene B4GALT1 correlates with the recruitment of immunosuppressive cells, creating a "double whammy" of cancer progression and immune shielding. Similarly, Baohong Jiang et al. utilized the method to demonstrate how the mitochondrial protein NDUFAF6 helps breast cancer tumors evade the immune system by boosting PD-L1 expression, a key checkpoint that "turns off" T-cells (Impact of NDUFAF6 on breast cancer prognosis: linking mitochondrial regulation to immune response and PD-L1 expression).

This mapping is not limited to cancer. In neurobiology, Rui Wang et al. applied ssGSEA to Alzheimer’s disease samples to link neuronal death to specific neuroinflammatory cell populations (Identification of immunogenic cell death-related genes involved in Alzheimer’s disease).

From Profiling to Prognostic Risk Scores

Beyond identifying single genes, ssGSEA allows researchers to build complex "risk models" that predict patient outcomes. By quantifying the functional state of the tumor microenvironment (TME), these models can identify which patients are likely to respond to immunotherapy.

Identifying "High Infiltration but Low Action"

A critical insight provided by ssGSEA is the distinction between the presence of immune cells and their activity. Yanfei Jia et al. described a paradoxical state in aggressive brain tumors termed "high infiltration but low action." While ssGSEA scores showed the tumors were packed with immune cells, further analysis revealed these cells were largely inactive or suppressed by neutrophils (Immune infiltration in aggressive papillary craniopharyngioma: High infiltration but low action).

By providing a sample-specific lens into these cellular dynamics, ssGSEA has become a cornerstone of "immune fitness" profiling. As argued by Farnoosh Abbas Aghababazadeh et al., these computational scores allow us to harness the "cancer immunity cycle," moving away from one-size-fits-all treatments toward personalized strategies based on the unique cellular landscape of each patient's disease (1197 Harnessing the cancer immunity cycle via machine learning models to generate novel strategies for personalized cancer therapy).

History & citationVersion 1 · 2026-10-04

Current · Permanent link

View frozen version 1

Cite this direction

Latest version (a living page):

@misc{lacuna_single_sample_gene_set_enrichment_analys_0529de56,
  title = {single-sample gene set enrichment analysis},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/single-sample-gene-set-enrichment-analysis/rdr_0529de5668bb45548c040134573fd82f},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}

This exact version (version 1, frozen text):

@misc{lacuna_single_sample_gene_set_enrichment_analys_0529de56_v1,
  title = {single-sample gene set enrichment analysis},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/single-sample-gene-set-enrichment-analysis/rdr_0529de5668bb45548c040134573fd82f/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}
About

These directions overlap with this one through shared papers.

See something wrong? Report a mistake